Literature DB >> 11173568

Complement Synthesis Influencing Factors Produced by Acute Myeloid Leukemia Blast Cells.

Béla Schmidt1, Márta Válay, Sarolta Nahajevszky, Ervin Pitlik, György Füst.   

Abstract

In a previous study, we found hypercomplementaemia in the sera of acute myeloid leukemia patients. In this study we show that the supernatants of mononuclear cells, derived from peripheral blood taken in the blastic phase, from patients with acute myeloid leukemia (CM-AML) increased the in vitro complement protein synthesis of HepG2 hepatocellular carcinoma cells. This effect of CM-AML was mediated by heat labile soluble factors and involved the synthesis of mRNA and protein. Inhibition experiments with anti-cytokine antibodies and immunoaffinity chromatography revealed that this effect of CM-AML is mostly mediated by IL-1 and IL-6.

Entities:  

Year:  1995        PMID: 11173568     DOI: 10.1007/bf02893584

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  19 in total

1.  Hormonal regulation of complement biosynthesis in human cell lines--II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line.

Authors:  A Falus; H Rokita; E Walcz; M Brozik; T Hidvégi; K Merétey
Journal:  Mol Immunol       Date:  1990-02       Impact factor: 4.407

2.  Abnormalities of complement and its components in patients with acute leukemia, Hodgkin's disease, and sarcoma.

Authors:  J L Lichtenfeld; P H Wiernik; M R Mardiney; R M Zarco
Journal:  Cancer Res       Date:  1976-10       Impact factor: 12.701

3.  Modulation of cell proliferation and cytokine production in AML by recombinant interleukin-1 receptor antagonist.

Authors:  A Rambaldi; M Torcia; C A Dinarello; T Barbui; F Cozzolino
Journal:  Leukemia       Date:  1993-08       Impact factor: 11.528

4.  Effect of conditioned media of acute myeloid leukemia blast cells on complement synthesis by cultured human cells of monocyte and hepatocyte origin.

Authors:  G Gyapay; B Schmidt; M Válay; A Falus; N Anh-Tuan; A Pánya; M Kókai; K Onody; A Mód; G Füst
Journal:  Complement Inflamm       Date:  1991

5.  Human C'3: evidence for the liver as the primary site of synthesis.

Authors:  C A Alper; A M Johnson; A G Birtch; F D Moore
Journal:  Science       Date:  1969-01-17       Impact factor: 47.728

6.  Inhibition of acute myelogenous leukemia blast proliferation by interleukin-1 (IL-1) receptor antagonist and soluble IL-1 receptors.

Authors:  Z Estrov; R Kurzrock; E Estey; M Wetzler; A Ferrajoli; D Harris; M Blake; J U Gutterman; M Talpaz
Journal:  Blood       Date:  1992-04-15       Impact factor: 22.113

7.  Increase of serum complement levels in cancer patients with progressing tumors.

Authors:  H Verhaegen; W De Cock; J De Cree; F Verbruggen
Journal:  Cancer       Date:  1976-10       Impact factor: 6.860

8.  Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen.

Authors:  B B Knowles; C C Howe; D P Aden
Journal:  Science       Date:  1980-07-25       Impact factor: 47.728

9.  Complement C1-inactivator in the serum of patients with malignant disease.

Authors:  J Astrup; H Colstrup; B Frandsen
Journal:  Acta Radiol Ther Phys Biol       Date:  1977-10

10.  Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alfa levels are significantly increased in acute myeloid leukemia patients.

Authors:  G Cimino; S Amadori; M C Cava; V De Sanctis; M C Petti; A O Di Gregorio; C Sgadari; L Vegna; G Cimino; F Mandelli
Journal:  Leukemia       Date:  1991-01       Impact factor: 11.528

View more
  1 in total

1.  Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.

Authors:  Cinzia Scambi; Valentina La Verde; Lucia De Franceschi; Giovanni Barausse; Fabio Poli; Fabio Benedetti; Marco Sorio; Francesca Deriu; Paola Roncada; Oscar Bortolami; Francesco Turrini; Paola Caramaschi; Chiara Stranieri; Lisa M Bambara; Domenico Biasi
Journal:  PLoS One       Date:  2010-08-13       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.